Skip to main content

Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug

Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.